Acrycoat L 12,5 represents a premium methacrylic acid copolymer type C solution, specifically formulated as a 12.5% clear solution in isopropanol that meets stringent USP/NF and EP...

Acrycoat L 12,5 represents a premium methacrylic acid copolymer type C solution, specifically formulated as a 12.5% clear solution in isopropanol that meets stringent USP/NF and EP specifications. This high-purity material creates films that remain insoluble in gastric fluid while becoming soluble in the intestinal tract at pH levels of 5.5 and above, making it an optimal choice for enteric coating applications. The resulting film is colorless, transparent, and initially brittle, but offers excellent flexibility for modification with plasticizers to achieve desired elasticity and performance characteristics. Its consistent quality and reliable performance make it a preferred material for pharmaceutical manufacturers seeking compliant and effective coating solutions that maintain product integrity throughout the manufacturing process.

This specialized copolymer finds extensive application across pharmaceutical manufacturing sectors, particularly for coating tablets, capsules, and various solid dosage forms. It serves as an essential component for drugs requiring protection from stomach acid or those needing targeted release in specific intestinal regions. The product supports diverse industry segments including generic pharmaceuticals, nutraceuticals, and specialty drug formulations by enhancing drug stability, improving patient compliance through better therapeutic outcomes, and ensuring consistent performance. Its alignment with global pharmacopeia standards facilitates regulatory compliance across international markets, making it suitable for both domestic production and export-oriented pharmaceutical operations seeking reliable enteric coating solutions.

Acrycoat L 12,5 delivers substantial business value through its proven reliability, consistent performance, and quality assurance. It minimizes production risks by adhering to strict quality benchmarks, reducing batch failures and ensuring smooth manufacturing operations. The material's adaptability through plasticizer modification allows manufacturers to customize film properties according to specific product requirements, enabling product differentiation and optimization. By providing effective enteric protection, it contributes to extended drug shelf life and improved therapeutic efficacy, ultimately leading to enhanced patient outcomes and customer satisfaction. This combination of durability, effectiveness, and regulatory compliance makes it a cost-efficient solution for long-term pharmaceutical manufacturing needs.

Key Features:
- Complies with USP/NF and EP specifications for methacrylic acid copolymer type C
- 12.5% clear isopropanol solution ensuring easy application and processing
- Forms gastric fluid-insoluble films that dissolve at intestinal pH 5.5+
- Transparent, colorless brittle film modifiable with plasticizers
- Rigorous quality control ensures high purity and batch consistency

Benefits:
- Ensures regulatory compliance with international pharmacopeia standards
- Provides reliable gastric protection with targeted intestinal release
- Offers formulation flexibility through plasticizer customization
- Enhances drug stability and extends product shelf life
- Delivers consistent performance across manufacturing batches